Zhongnan Hospital
Clinical trials sponsored by Zhongnan Hospital, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Eyeliner may dry your eyes: new study investigates Results expected Sep 2026 (estimated)
- Minimally invasive eye surgery could ease a rare form of glaucoma Results expected Sep 2026 (estimated)
- New eye drainage procedure aims to lower pressure in advanced glaucoma Results expected Dec 2026 (estimated)
- Immunotherapy plus chemo shows promise in rectal cancer trial Results expected Jan 2027 (estimated)
- Which brain target eases Parkinson's symptoms best? a Head-to-Head test Results expected Jan 2027 (estimated)
-
New fluid aims to keep donated kidneys healthier
Disease control OngoingResearchers compare two fluids used to preserve donor kidneys before transplant: a new solution called HCA-N and the standard HTK solution. The trial enrolls 250 first-time kidney transplant recipients aged 18 to 65. Doctors check how often kidneys need dialysis within the first …
Phase 2/3 • Sponsor: Zhongnan Hospital • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
New eye drainage procedure aims to lower pressure in advanced glaucoma
Disease control OngoingThis study tests a new, less invasive drainage procedure for people with advanced neovascular glaucoma whose eye pressure remains high despite treatment. The goal is to safely lower eye pressure and reduce the need for pressure-lowering drugs. The study involves 30 participants a…
Sponsor: Zhongnan Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC